<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stocks.org &#187; SPLK</title>
	<atom:link href="http://stocks.org/quotes/splk/feed/" rel="self" type="application/rss+xml" />
	<link>http://stocks.org</link>
	<description>Your reliable source for market news and financial insight</description>
	<lastBuildDate>Wed, 16 Mar 2016 20:39:51 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.9.20</generator>
	<item>
		<title>A 20% jump for Splunk Inc (NASDAQ:SPLK) as New Consumers bring in more Revenue for the company $SPLK</title>
		<link>http://stocks.org/company/a-20-jump-for-splunk-inc-nasdaqsplk-as-new-consumers-bring-in-more-revenue-for-the-company-splk/25195/</link>
		<comments>http://stocks.org/company/a-20-jump-for-splunk-inc-nasdaqsplk-as-new-consumers-bring-in-more-revenue-for-the-company-splk/25195/#comments</comments>
		<pubDate>Mon, 01 Sep 2014 13:00:52 +0000</pubDate>
		<dc:creator><![CDATA[Erik Waters]]></dc:creator>
				<category><![CDATA[Company]]></category>
		<category><![CDATA[JWN]]></category>
		<category><![CDATA[nordstrom]]></category>
		<category><![CDATA[SCTY]]></category>
		<category><![CDATA[solarcity]]></category>
		<category><![CDATA[SPLK]]></category>
		<category><![CDATA[splunk]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=5195</guid>
		<description><![CDATA[On surface, SolarCity Corp (NASDAQ:SCTY), Nordstrom, Inc (NYSE:JWN) and the U.S. Department of Health and Human Services (DHHS) share a very narrow or absolutely no common grounds. Their procedures and ventures contrast and are very unlike, or so it seems. However, they have an imperative mutual interest – they all are scrutinizing Big Data. This common ground has brought them<div class="read-more"><a href="http://stocks.org/company/a-20-jump-for-splunk-inc-nasdaqsplk-as-new-consumers-bring-in-more-revenue-for-the-company-splk/25195/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/company/a-20-jump-for-splunk-inc-nasdaqsplk-as-new-consumers-bring-in-more-revenue-for-the-company-splk/25195/">A 20% jump for Splunk Inc (NASDAQ:SPLK) as New Consumers bring in more Revenue for the company $SPLK</a> was first posted on September 1, 2014 at 9:00 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[
<!-- Easy AdSense V7.22 -->
<!-- [leadin: 2 urCount: 2 urMax: 0] -->
<div class="ezAdsense adsense adsense-leadin" style="float:right;margin:12px;"><script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- Sample one -->
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-7728471989081824"
     data-ad-slot="6234561790"
     data-ad-format="auto"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></div>
<!-- Easy AdSense V7.22 -->
<p>On surface, SolarCity Corp (NASDAQ:SCTY), <a href="http://www.forbes.com/companies/nordstrom/">Nordstrom</a>, Inc (NYSE:JWN) and the U.S. Department of <a href="http://www.forbes.com/health/">Health</a> and Human Services (DHHS) share a very narrow or absolutely no common grounds. Their procedures and ventures contrast and are very unlike, or so it seems.</p>
<p>However, they have an imperative mutual interest – they all are scrutinizing Big Data. This common ground has brought them all to one platform where they have become the clients of the same company <a href="http://www.forbes.com/companies/splunk/">Splunk</a>, <a href="http://www.forbes.com/companies/splunk/">Inc (NASDAQ:SPLK).</a>However, DHHS and Nordstrom, Inc (NYSE:JWN) are not the only customers the company currently has.</p>
<p>After the close down on Thursday, the company announced its earnings results for the second quarter; it also said that its total clientele has gone up by 7%, that increased the revenue over 50%; this results in a 20% jump in the company’s stock during Friday’s trading.</p>
<p>Splunk, Inc (NASDAQ:SPLK) offers instruments and devices and provides analysis and assessments that assist companies to sort out and comprehend their data. It was reported on Thursday that, so far the company has recorded up to $101.5 million in revenue for their second quarter. It is a 52% improvement from last year’s second quarter. With this figure they have beaten a few predictions. Gross earnings, omitting exclusive items, came down to 1 cent per share, defeating the two-cent/share cost that was predicted. The customer list for the company was mainly responsible for these healthy results; Splunk, Inc (NASDAQ:SPLK) claimed it commenced and increased its services for special customers, not just for SolarCity Corp (NASDAQ:SCTY) and Nordstrom, Inc (NYSE:JWN), but this list also included Vermontstate, Australia’s National Revenue Office, Victoria, and France’s postal services system, La Poste.</p>
<p>Brent Till, a UBS analyst, said on Friday that Splunk, Inc (NASDAQ:SPLK) proved the expectations of bearish consensus wrong into the print of F2Q15; it did so by showing great growth in revenues, andpunter growth. The company enjoys 70% license bookings from its current customer base, which means that it has what it takes to retain its customers.</p>
<p>UBS changed their Splunk Inc (NASDAQ:SPLK) rating of buy and reduced the price target to a value of $55/share; it is a decrease by $1 only. Till believes the company to be an extraordinary discovery amongst public limited tech investments that is connected straight to movements around Big Data.</p>
<p>A Canaccord Genuity analyst, Richard Davis also changed Splunk Inc (NASDAQ:SPLK)’s buy rating and reduced the price target to $60/share from $70 previously. He also mentioned that Splunk, Inc (NASDAQ:SPLK) is very reasonably priced currently.</p>
<p>With such convincing and formidable earnings and outcomes, Splunk, Inc (NASDAQ:SPLK) is looking to increase its revenue guidance for full year within the range of $423 million and $428 million, which previously was between $402 and $410.</p>
<p>Friday was the company’s first trading day after releasing its great results; the stock kicked off the session at $3 higher than the previous rate and was successful to get a gain by 21%. However, it still has more to gain because compared to the first trading day in 2014 it’s down over 36%.</p>
<p>&nbsp;</p>
<hr style="border-top:black solid 1px" /><a href="http://stocks.org/company/a-20-jump-for-splunk-inc-nasdaqsplk-as-new-consumers-bring-in-more-revenue-for-the-company-splk/25195/">A 20% jump for Splunk Inc (NASDAQ:SPLK) as New Consumers bring in more Revenue for the company $SPLK</a> was first posted on September 1, 2014 at 9:00 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/company/a-20-jump-for-splunk-inc-nasdaqsplk-as-new-consumers-bring-in-more-revenue-for-the-company-splk/25195/feed/</wfw:commentRss>
		<slash:comments>574</slash:comments>
		</item>
		<item>
		<title>Most Volatile: Galectin Therapeutics Inc. (NASDAQ:GALT), Arrowhead Research Corp (NASDAQ:ARWR), Splunk Inc. (NASDAQ:SPLK), Intellicheck Mobilisa, Inc. (NYSEMKT:IDN)</title>
		<link>http://stocks.org/market/most-volatile-galectin-therapeutics-inc-nasdaqgalt-arrowhead-3337/2337/</link>
		<comments>http://stocks.org/market/most-volatile-galectin-therapeutics-inc-nasdaqgalt-arrowhead-3337/2337/#comments</comments>
		<pubDate>Mon, 30 Nov -0001 00:00:00 +0000</pubDate>
		<dc:creator><![CDATA[mmejia]]></dc:creator>
				<category><![CDATA[Market]]></category>
		<category><![CDATA[ARWR]]></category>
		<category><![CDATA[IDN]]></category>
		<category><![CDATA[SPLK]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced that on Monday, March 31, 2014, the Company will report results from the first cohort of its Phase 1 clinical trial examining GR-MD-02 in fatty liver disease (NASH) with advanced fibrosis. On last trading day Galectin Therapeutics<div class="read-more"><a href="http://stocks.org/market/most-volatile-galectin-therapeutics-inc-nasdaqgalt-arrowhead-3337/2337/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/market/most-volatile-galectin-therapeutics-inc-nasdaqgalt-arrowhead-3337/2337/">Most Volatile: Galectin Therapeutics Inc. (NASDAQ:GALT), Arrowhead Research Corp (NASDAQ:ARWR), Splunk Inc. (NASDAQ:SPLK), Intellicheck Mobilisa, Inc. (NYSEMKT:IDN)</a> was first posted on March 26, 2014 at 2:29 pm.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[<p>Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced that on Monday, March 31, 2014, the Company will report results from the first cohort of its Phase 1 clinical trial examining GR-MD-02 in fatty liver disease (NASH) with advanced fibrosis. On last trading day Galectin Therapeutics Inc. (NASDAQ:GALT) ended up 8.84%higher to close at $15.88 while trading in the range of $15.63 &#8211; $18.62. Its return on assets (ROA) is -314.50%. Galectin Therapeutics Inc. (NASDAQ:GALT) monthly performance is 2.19%.</p>
<p>Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that patient dosing has begun in a Phase 2a clinical trial of ARC-520, its RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection. Arrowhead Research Corp (NASDAQ:ARWR) in last trading activity ended up at $17.22 with day range of $16.18 &#8211; $17.93. Company weekly performance is -28.58% while its quarterly performance stands at 73.41%.Arrowhead Research Corp (NASDAQ:ARWR) is -37.68% away from its 52 week high.</p>
<p>Splunk (NASDAQ:SPLK) CEO Godfrey Sullivan unloaded 20,000 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $88.29, for a total value of $1,765,800.00. Following the transaction, the chief executive officer now directly owns 557,190 shares in the company, valued at approximately $49,194,305. Splunk Inc. (NASDAQ:SPLK) belongs to Technology sector with market capitalization of 8.02 billion and has 1.40% insider ownership. In last trading activity company’s stock closed at $74.20 while opening price was $79.17.</p>
<p>Intellicheck Mobilisa, Inc. (NYSEMKT:IDN), a global leader in identity solutions and wireless security systems, has released its financial results for the fourth quarter and full year ended December 31, 2013. On Tuesday shares of Intellicheck Mobilisa, Inc. (NYSEMKT:IDN) opened at $1.18 and closed at $1.10. This year Company’s Earnings per Share (EPS) growth is -0.13. Analysts mean target price for Intellicheck Mobilisa, Inc. (NYSEMKT:IDN) is $5.00.</p>
 <!-- Easy AdSense Unfiltered [count: 3 is not less than 3] --><hr style="border-top:black solid 1px" /><a href="http://stocks.org/market/most-volatile-galectin-therapeutics-inc-nasdaqgalt-arrowhead-3337/2337/">Most Volatile: Galectin Therapeutics Inc. (NASDAQ:GALT), Arrowhead Research Corp (NASDAQ:ARWR), Splunk Inc. (NASDAQ:SPLK), Intellicheck Mobilisa, Inc. (NYSEMKT:IDN)</a> was first posted on March 26, 2014 at 2:29 pm.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/market/most-volatile-galectin-therapeutics-inc-nasdaqgalt-arrowhead-3337/2337/feed/</wfw:commentRss>
		<slash:comments>829</slash:comments>
		</item>
	</channel>
</rss>
